Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79478801Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$341.7M
Full award amounts, FY2024
Award Records
43
Records listing this PI
Award-Linked Rank
#1
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Lynn Briscoe as a PI. Multi-PI records show the full award amount for context.
- 75N91019D00024-0-759102400011-22N01NCI-Frederick Operational Support$115.8Maward amount
- 75N91019D00024-0-759102400011-7N01Division of Cancer Treatment and Diagnosis- Operational Task Order$51.7Maward amount
- $26.9Maward amount
- $18.5Maward amount
- 75N91019D00024-0-759102400011-4N01DCEG- Genotyping for epidemiology studies$17.5Maward amount
- 75N91019D00024-0-759102400027-1N01FY24/FY25 FFRDC LEASES OPERATIONAL TASK ORDER$17Maward amount
- 75N91019D00024-0-759102400011-13N01NCI-F Operations and Technical Support II$16.2Maward amount
- $12.7Maward amount
- 75N91019D00024-0-759102400030-1N01ARPA-H BIOMEDICAL DATA FABRIC TOOLBOX PROGRAM$11.9Maward amount
- 75N91019D00024-0-759102400029-1N01PROTEOMIC AND ANTIBODY PRODUCTION AND CHARACTERIZATION$10.7Maward amount
+33 more grants not shown.
Award organization
Organizations that administered FY2024 awards listing Lynn Briscoe as a PI.
FY2024 award administered by Leidos Biomedical Research, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardLeidos Biomedical Research, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024$10M Cumulative Funding
- 2024$25M Cumulative Funding
- 2024$50M Cumulative Funding
- 2024$100M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1
- 2024Entered Top 25% NationallyRanked #1
- 2024Entered Top 10% NationallyRanked #1
- 2024Entered Top 5% NationallyRanked #1
- 2024Entered Top 1% NationallyRanked #1